1. Cell Biology
  2. Developmental Biology

HSF-1 activates the ubiquitin proteasome system to promote non-ppoptotic developmental cell death in C. elegans

  1. Maxime J Kinet
  2. Jennifer A Malin
  3. Mary C Abraham
  4. Elyse S Blum
  5. Melanie R Silverman
  6. Yun Lu
  7. Shai Shaham  Is a corresponding author
  1. The Rockefeller University, United States
https://doi.org/10.7554/eLife.12821
Share this article
Cite this article
  1. Maxime J Kinet
  2. Jennifer A Malin
  3. Mary C Abraham
  4. Elyse S Blum
  5. Melanie R Silverman
  6. Yun Lu
  7. Shai Shaham
(2016)
HSF-1 activates the ubiquitin proteasome system to promote non-ppoptotic developmental cell death in C. elegans
eLife 5:e12821.
https://doi.org/10.7554/eLife.12821
  2. Download BibTeX
  3. Download .RIS

Abstract

Apoptosis is a prominent metazoan cell death form. Yet, mutations in apoptosis regulators cause only minor defects in vertebrate development, suggesting that another developmental cell death mechanism exists. While some non-apoptotic programs are characterized, none appear to control developmental cell-culling. Linker-cell-type death (LCD) is a morphologically conserved non-apoptotic cell death process operating in C. elegans and vertebrate development, and is therefore a compelling candidate-process complementing apoptosis. However, details of LCD execution are not known. Here we delineate a molecular-genetic pathway governing LCD in C. elegans. Redundant activities of antagonistic Wnt signals, a temporal-control pathway, and MAPKK signaling control HSF-1, a conserved stress-activated transcription factor. Rather than protecting cells, HSF-1 promotes their demise by activating components of the ubiquitin-proteasome-system, including the E2-ligase LET-70/UBE2D2 functioning with E3 components CUL-3, RBX-1, TAG-30/BTBD2, and SIAH-1. Our studies uncover design similarities between LCD and developmental apoptosis, and provide testable predictions for analyzing LCD in vertebrates.

Article and author information

Author details

  1. Maxime J Kinet

    Laboratory of Developmental Genetics, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.

  2. Jennifer A Malin

    Laboratory of Developmental Genetics, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.

  3. Mary C Abraham

    Laboratory of Developmental Genetics, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.

  4. Elyse S Blum

    Laboratory of Developmental Genetics, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.

  5. Melanie R Silverman

    Laboratory of Developmental Genetics, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.

  6. Yun Lu

    Laboratory of Developmental Genetics, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.

  7. Shai Shaham

    Laboratory of Developmental Genetics, The Rockefeller University, New York, United States
    For correspondence
    shaham@rockefeller.edu
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Oliver Hobert, Howard Hughes Medical Institute, Columbia University, United States

Version history

  1. Received: November 4, 2015
  2. Accepted: March 7, 2016
  3. Accepted Manuscript published: March 8, 2016 (version 1)
  4. Accepted Manuscript updated: March 9, 2016 (version 2)
  5. Version of Record published: March 30, 2016 (version 3)

Copyright

© 2016, Kinet et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,464
    views
  • 783
    downloads
  • 20
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Maxime J Kinet
  2. Jennifer A Malin
  3. Mary C Abraham
  4. Elyse S Blum
  5. Melanie R Silverman
  6. Yun Lu
  7. Shai Shaham
(2016)
HSF-1 activates the ubiquitin proteasome system to promote non-ppoptotic developmental cell death in C. elegans
eLife 5:e12821.
https://doi.org/10.7554/eLife.12821

Share this article

https://doi.org/10.7554/eLife.12821

Categories and tags

Research organism

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology

    MEMO1 binds iron and modulates iron homeostasis in cancer cells

    Natalia Dolgova, Eva-Maria E Uhlemann ... Oleg Y Dmitriev
    Research Article Updated

    Mediator of ERBB2-driven cell motility 1 (MEMO1) is an evolutionary conserved protein implicated in many biological processes; however, its primary molecular function remains unknown. Importantly, MEMO1 is overexpressed in many types of cancer and was shown to modulate breast cancer metastasis through altered cell motility. To better understand the function of MEMO1 in cancer cells, we analyzed genetic interactions of MEMO1 using gene essentiality data from 1028 cancer cell lines and found multiple iron-related genes exhibiting genetic relationships with MEMO1. We experimentally confirmed several interactions between MEMO1 and iron-related proteins in living cells, most notably, transferrin receptor 2 (TFR2), mitoferrin-2 (SLC25A28), and the global iron response regulator IRP1 (ACO1). These interactions indicate that cells with high-MEMO1 expression levels are hypersensitive to the disruptions in iron distribution. Our data also indicate that MEMO1 is involved in ferroptosis and is linked to iron supply to mitochondria. We have found that purified MEMO1 binds iron with high affinity under redox conditions mimicking intracellular environment and solved MEMO1 structures in complex with iron and copper. Our work reveals that the iron coordination mode in MEMO1 is very similar to that of iron-containing extradiol dioxygenases, which also display a similar structural fold. We conclude that MEMO1 is an iron-binding protein that modulates iron homeostasis in cancer cells.

    1. Cell Biology

    Pigmentation level of human iPSC-derived RPE does not indicate a specific gene expression profile

    Yoko Nakai-Futatsugi, Jianshi Jin ... Masayo Takahashi
    Research Article

    Retinal pigment epithelium (RPE) cells show heterogeneous levels of pigmentation when cultured in vitro. To know whether their color in appearance is correlated with the function of the RPE, we analyzed the color intensities of human-induced pluripotent stem cell-derived RPE cells (iPSC-RPE) together with the gene expression profile at the single-cell level. For this purpose, we utilized our recent invention, Automated Live imaging and cell Picking System (ALPS), which enabled photographing each cell before RNA-sequencing analysis to profile the gene expression of each cell. While our iPSC-RPE were categorized into four clusters by gene expression, the color intensity of iPSC-RPE did not project any specific gene expression profiles. We reasoned this by less correlation between the actual color and the gene expressions that directly define the level of pigmentation, from which we hypothesized the color of RPE cells may be a temporal condition not strongly indicating the functional characteristics of the RPE.

    1. Cancer Biology
    2. Cell Biology

    CYRI-B mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake

    Savvas Nikolaou, Amelie Juin ... Laura M Machesky
    Research Article

    Pancreatic ductal adenocarcinoma carries a dismal prognosis, with high rates of metastasis and few treatment options. Hyperactivation of KRAS in almost all tumours drives RAC1 activation, conferring enhanced migratory and proliferative capacity as well as macropinocytosis. Macropinocytosis is well understood as a nutrient scavenging mechanism, but little is known about its functions in trafficking of signaling receptors. We find that CYRI-B is highly expressed in pancreatic tumours in a mouse model of KRAS and p53-driven pancreatic cancer. Deletion of Cyrib (the gene encoding CYRI-B protein) accelerates tumourigenesis, leading to enhanced ERK and JNK-induced proliferation in precancerous lesions, indicating a potential role as a buffer of RAC1 hyperactivation in early stages. However, as disease progresses, loss of CYRI-B inhibits metastasis. CYRI-B depleted tumour cells show reduced chemotactic responses to lysophosphatidic acid, a major driver of tumour spread, due to impaired macropinocytic uptake of the lysophosphatidic acid receptor-1. Overall, we implicate CYRI-B as a mediator of growth and signaling in pancreatic cancer, providing new insights into pathways controlling metastasis.